1. Company List - P
2. PGNX

Insider Trading activities at Progenics Pharmaceuticals Inc (PGNX) , Part 3

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Progenics Pharmaceuticals Inc (PGNX) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Progenics Pharmaceuticals Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. The reporting company's CIK number is 835887.

Total stock buying since 2005: $11,893,679.
Total stock sales since 2005: $30,175,090.
Total stock option exercises since 2005: $9,421,383.

▪ Recent SEC 13D filings for PGNX
▪ Recent SEC 13D filings for all companies
▪ Funds & ETFs holding PGNX
▪ Recent portfolio reports of all companies

A schedule 13D must be filed with the SEC when a person or group of persons acquires beneficial ownership of more than 5% of Progenics Pharmaceuticals Inc (PGNX). A schedule 13D/A is an amendment that is filed when there are any material changes in beneficial ownership.

Table 2. Monthly summary of insider trading at Progenics Pharmaceuticals Inc (PGNX).

Trading Period	Insider Buying		Insider Sales		Option Exercises
year-month	Shares	Value	Shares	Value	Shares	Value
2019-09	658,061	$2,984,404	0	$0	0	$0
2019-08	204,056	$878,618	0	$0	0	$0
2019-07	0	$0	0	$0	22,000	$111,979
2019-06	0	$0	0	$0	50,000	$267,000
2017-02	0	$0	953,900	$9,227,413	0	$0
2015-06	0	$0	2,000	$13,660	2,000	$10,660
2015-03	0	$0	10,000	$67,110	10,000	$50,209
2015-01	0	$0	2,000	$14,112	2,000	$10,660
2014-12	0	$0	3,000	$21,201	3,000	$16,049
2014-11	0	$0	24,000	$163,950	24,000	$126,600
2014-07	1,625,436	$7,476,167	0	$0	0	$0
2013-07	0	$0	5,000	$31,650	5,000	$26,650
2013-03	650	$3,469	0	$0	2,500	$9,097
2013-01	1,215	$3,432	0	$0	0	$0
2012-12	1,142	$3,437	0	$0	0	$0
2012-11	112,033	$199,577	0	$0	0	$0
2012-10	1,162	$3,433	0	$0	0	$0
2012-09	1,036	$3,439	0	$0	0	$0
2012-08	815	$3,450	0	$0	0	$0
2012-07	346	$3,472	1,000	$9,790	1,000	$5,330
2012-06	375	$3,474	1,000	$8,508	1,000	$5,330
2012-05	445	$3,475	1,000	$10,927	1,000	$5,330
2012-04	348	$3,514	1,000	$9,852	1,000	$5,330
2012-03	343	$3,472	1,000	$9,817	1,000	$5,330
2012-02	369	$3,484	35,250	$359,205	2,250	$13,955
2012-01	755	$6,924	1,000	$8,780	1,000	$5,330
2011-12	0	$0	1,000	$6,660	1,000	$5,330
2011-11	0	$0	1,634	$9,785	1,000	$5,330
2011-10	532	$3,467	1,000	$6,330	15,104	$70,545
2011-09	542	$3,460	1,000	$6,329	1,000	$5,329
2011-08	571	$3,471	1,000	$6,330	1,000	$5,330
2011-07	567	$3,471	1,000	$7,205	42,968	$233,998
2011-06	490	$3,469	14,761	$106,382	1,000	$5,330
2011-05	486	$3,465	21,000	$172,290	1,000	$5,330
2011-04	479	$3,467	1,000	$6,330	13,222	$67,376
2011-03	0	$0	1,000	$6,330	33,500	$48,555
2011-02	0	$0	7,597	$48,089	7,597	$40,492
2011-01	0	$0	403	$2,550	13,702	$66,353
2010-12	5,000	$24,500	0	$0	0	$0
2010-11	5,000	$23,800	0	$0	0	$0
2010-10	5,000	$24,950	0	$0	41,475	$179,086
2010-09	5,000	$20,500	0	$0	0	$0
2010-08	5,000	$23,750	0	$0	0	$0
2010-07	5,000	$24,925	0	$0	16,056	$71,288
2010-06	5,000	$24,950	17,281	$101,687	0	$0
2010-05	5,000	$24,550	0	$0	0	$0
2010-04	0	$0	0	$0	20,792	$94,726
2010-03	0	$0	9,221	$49,429	0	$0
2010-01	0	$0	0	$0	18,226	$68,947
2009-10	18,500	$90,243	0	$0	15,442	$65,765
2009-07	0	$0	0	$0	43,354	$231,075
2009-06	0	$0	9,500	$47,548	0	$0
2009-04	0	$0	0	$0	12,279	$69,376
2009-01	0	$0	0	$0	7,849	$71,660
2008-10	0	$0	62,500	$577,625	37,563	$245,280
2008-09	0	$0	1,000	$15,000	1,000	$12,290
2008-08	0	$0	1,000	$16,465	51,000	$493,540
2008-07	0	$0	11,000	$175,942	27,040	$298,518
2008-06	0	$0	1,000	$16,397	1,000	$12,290
2008-05	0	$0	1,000	$15,000	8,500	$52,512
2008-04	0	$0	1,000	$15,000	14,792	$102,212
2008-03	0	$0	1,000	$15,300	8,500	$47,247
2008-02	0	$0	1,000	$16,440	1,000	$12,290
2008-01	0	$0	1,000	$18,120	5,986	$88,793
2007-12	0	$0	6,000	$115,351	6,000	$42,040
2007-10	0	$0	27,000	$616,692	49,797	$646,256
2007-09	0	$0	24,000	$565,908	24,000	$127,920
2007-08	0	$0	26,000	$578,410	26,000	$158,734
2007-07	0	$0	26,000	$560,601	36,536	$422,852
2007-06	0	$0	14,000	$305,066	14,000	$94,774
2007-05	0	$0	26,000	$613,960	26,000	$158,734
2007-04	0	$0	30,000	$769,362	34,393	$384,612
2007-03	0	$0	36,000	$898,714	36,000	$198,734
2007-02	0	$0	62,000	$1,858,002	62,000	$332,680
2007-01	0	$0	38,500	$1,062,826	51,232	$478,080
2006-12	0	$0	50,000	$1,344,807	50,000	$258,300
2006-11	0	$0	52,000	$1,433,356	52,000	$262,734
2006-10	0	$0	33,000	$789,341	38,192	$371,915
2006-09	0	$0	29,000	$672,728	29,000	$147,920
2006-08	0	$0	29,000	$609,252	29,000	$147,920
2006-07	0	$0	29,000	$658,453	43,904	$532,616
2006-06	0	$0	37,025	$803,159	15,000	$73,300
2006-05	0	$0	39,000	$897,840	39,000	$182,600
2006-04	0	$0	25,000	$639,440	29,231	$271,170
2006-03	0	$0	32,000	$905,380	32,000	$154,600
2006-02	0	$0	50,500	$1,407,893	49,000	$318,850
2006-01	0	$0	8,000	$221,064	12,528	$203,010
2005-09	0	$0	5,000	$125,000	0	$0
2005-06	0	$0	15,150	$301,947	0	$0

Table 3. Detailed insider trading at Progenics Pharmaceuticals Inc (PGNX) , Part 3

Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2007-02-15	Boyd Thomas A (Sr. VP, Product Dev.)	Option Ex	4,000	17.19	68,760
2007-02-15	Maddon Paul J (Chief Executive Officer/CSO)	Sale	12,000	29.89	358,716
2007-02-15	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	12,000	5.33	63,960
2007-02-12	Mckinney Robert A (Chief Financial Officer)	Sale	4,000	29.48	117,908
2007-02-12	Mckinney Robert A (Chief Financial Officer)	Option Ex	4,000	4.00	16,000
2007-02-02	Scheinberg David A (Director)	Sale	30,000	30.09	902,850
2007-02-02	Scheinberg David A (Director)	Option Ex	30,000	4.00	120,000
2007-02-01	Maddon Paul J (Chief Executive Officer/CSO)	Sale	12,000	29.89	358,632
2007-02-01	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	12,000	5.33	63,960
2007-01-29	Mckinney Robert A (Chief Financial Officer)	Sale	4,000	29.72	118,872
2007-01-29	Mckinney Robert A (Chief Financial Officer)	Option Ex	4,000	4.00	16,000
2007-01-29	Baker Charles A (Director)	Sale	2,500	30.02	75,050
2007-01-29	Baker Charles A (Director)	Option Ex	2,500	19.50	48,750
2007-01-16	Mckinney Robert A (Chief Financial Officer)	Sale	4,000	28.79	115,160
2007-01-16	Mckinney Robert A (Chief Financial Officer)	Option Ex	4,000	4.00	16,000
2007-01-16	Maddon Paul J (Chief Executive Officer/CSO)	Sale	12,000	28.58	342,912
2007-01-16	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	12,000	5.33	63,960
2007-01-08	Scheinberg David A (Director)	Option Ex	8,000	4.00	32,000
2007-01-03	Baker Mark Robert (General Counsel)	Option Ex	571	21.88	12,493
2007-01-03	Boyd Thomas A (Sr. VP, Product Dev.)	Option Ex	428	21.88	9,364
2007-01-03	Kremer Alton B (VP, Clinical Research)	Option Ex	686	21.88	15,009
2007-01-03	Olson William C (VP, Research & Development)	Option Ex	362	21.88	7,920
2007-01-03	Mckinney Robert A (Chief Financial Officer)	Sale	4,000	25.68	102,708
2007-01-03	Mckinney Robert A (Chief Financial Officer)	Option Ex	4,428	12.94	57,298
2007-01-03	Maddon Paul J (Chief Executive Officer/CSO)	Sale	12,000	25.68	308,124
2007-01-03	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	13,614	13.61	185,218
2007-01-03	Israel Robert J (Sr. VP, Medical Affairs)	Option Ex	643	21.88	14,068
2006-12-15	Boyd Thomas A (Sr. VP, Product Dev.)	Sale	2,000	26.05	52,100
2006-12-15	Boyd Thomas A (Sr. VP, Product Dev.)	Option Ex	2,000	17.19	34,380
2006-12-15	Maddon Paul J (Chief Executive Officer/CSO)	Sale	12,000	26.14	313,668
2006-12-15	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	12,000	5.33	63,960
2006-12-11	Mckinney Robert A (Chief Financial Officer)	Sale	4,000	27.75	110,988
2006-12-11	Mckinney Robert A (Chief Financial Officer)	Option Ex	4,000	4.00	16,000
2006-12-04	Israel Robert J (Sr. VP, Medical Affairs)	Sale	5,000	28.00	140,000
2006-12-04	Israel Robert J (Sr. VP, Medical Affairs)	Option Ex	5,000	4.00	20,000
2006-12-01	Scheinberg David A (Director)	Sale	10,000	27.15	271,490
2006-12-01	Scheinberg David A (Director)	Option Ex	10,000	4.00	40,000
2006-12-01	Maddon Paul J (Chief Executive Officer/CSO)	Sale	12,000	26.83	321,996
2006-12-01	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	12,000	5.33	63,960
2006-12-01	Israel Robert J (Sr. VP, Medical Affairs)	Sale	5,000	26.91	134,565
2006-12-01	Israel Robert J (Sr. VP, Medical Affairs)	Option Ex	5,000	4.00	20,000
2006-11-27	Mckinney Robert A (Chief Financial Officer)	Sale	4,000	28.05	112,188
2006-11-27	Mckinney Robert A (Chief Financial Officer)	Option Ex	4,000	4.00	16,000
2006-11-15	Boyd Thomas A (Sr. VP, Product Dev.)	Sale	2,000	28.93	57,856
2006-11-15	Boyd Thomas A (Sr. VP, Product Dev.)	Option Ex	2,000	15.41	30,814
2006-11-15	Maddon Paul J (Chief Executive Officer/CSO)	Sale	12,000	29.16	349,944
2006-11-15	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	12,000	5.33	63,960
2006-11-13	Mckinney Robert A (Chief Financial Officer)	Sale	4,000	29.03	116,124
2006-11-13	Mckinney Robert A (Chief Financial Officer)	Option Ex	4,000	4.00	16,000
2006-11-10	Mckinney Robert A (Chief Financial Officer)	Sale	4,000	28.00	112,000
2006-11-10	Mckinney Robert A (Chief Financial Officer)	Option Ex	4,000	4.00	16,000
2006-11-10	Israel Robert J (Sr. VP, Medical Affairs)	Sale	5,000	28.00	140,000
2006-11-10	Israel Robert J (Sr. VP, Medical Affairs)	Option Ex	5,000	4.00	20,000
2006-11-01	Mckinney Robert A (Chief Financial Officer)	Sale	4,000	25.96	103,856
2006-11-01	Mckinney Robert A (Chief Financial Officer)	Option Ex	4,000	4.00	16,000
2006-11-01	Maddon Paul J (Chief Executive Officer/CSO)	Sale	12,000	25.96	311,568
2006-11-01	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	12,000	5.33	63,960
2006-11-01	Israel Robert J (Sr. VP, Medical Affairs)	Sale	5,000	25.96	129,820
2006-11-01	Israel Robert J (Sr. VP, Medical Affairs)	Option Ex	5,000	4.00	20,000
2006-10-27	Mckinney Robert A (Chief Financial Officer)	Sale	4,000	26.00	104,000
2006-10-27	Mckinney Robert A (Chief Financial Officer)	Option Ex	4,000	4.00	16,000
2006-10-16	Maddon Paul J (Chief Executive Officer/CSO)	Sale	12,000	24.00	288,000
2006-10-16	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	12,000	5.33	63,960
2006-10-02	Baker Mark Robert (General Counsel)	Option Ex	627	19.58	12,276
2006-10-02	Boyd Thomas A (Sr. VP, Product Dev.)	Option Ex	470	19.58	9,202
2006-10-02	Kremer Alton B (VP, Clinical Research)	Option Ex	752	19.58	14,724
2006-10-02	Olson William C (VP, Research & Development)	Option Ex	397	19.58	7,773
2006-10-02	Mckinney Robert A (Chief Financial Officer)	Option Ex	470	19.58	9,202
2006-10-02	Maddon Paul J (Chief Executive Officer/CSO)	Sale	12,000	23.37	280,476
2006-10-02	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	13,771	12.46	171,517
2006-10-02	Israel Robert J (Sr. VP, Medical Affairs)	Sale	5,000	23.37	116,865
2006-10-02	Israel Robert J (Sr. VP, Medical Affairs)	Option Ex	5,705	11.79	67,261
2006-09-15	Maddon Paul J (Chief Executive Officer/CSO)	Sale	12,000	23.87	286,488
2006-09-15	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	12,000	5.33	63,960
2006-09-01	Maddon Paul J (Chief Executive Officer/CSO)	Sale	12,000	22.72	272,640
2006-09-01	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	12,000	5.33	63,960
2006-09-01	Israel Robert J (Sr. VP, Medical Affairs)	Sale	5,000	22.72	113,600
2006-09-01	Israel Robert J (Sr. VP, Medical Affairs)	Option Ex	5,000	4.00	20,000
2006-08-15	Maddon Paul J (Chief Executive Officer/CSO)	Sale	12,000	20.20	242,412
2006-08-15	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	12,000	5.33	63,960
2006-08-01	Maddon Paul J (Chief Executive Officer/CSO)	Sale	12,000	21.57	258,840
2006-08-01	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	12,000	5.33	63,960
2006-08-01	Israel Robert J (Sr. VP, Medical Affairs)	Sale	5,000	21.60	108,000
2006-08-01	Israel Robert J (Sr. VP, Medical Affairs)	Option Ex	5,000	4.00	20,000
2006-07-17	Maddon Paul J (Chief Executive Officer/CSO)	Sale	12,000	21.10	253,224
2006-07-17	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	12,000	5.33	63,960
2006-07-03	Baker Mark Robert (General Counsel)	Option Ex	3,056	25.01	76,430
2006-07-03	Boyd Thomas A (Sr. VP, Product Dev.)	Option Ex	1,986	20.45	40,615
2006-07-03	Kremer Alton B (VP, Clinical Research)	Option Ex	2,262	20.45	46,260
2006-07-03	Olson William C (VP, Research & Development)	Option Ex	1,365	20.45	27,915
2006-07-03	Mckinney Robert A (Chief Financial Officer)	Option Ex	2,292	20.45	46,873
2006-07-03	Maddon Paul J (Chief Executive Officer/CSO)	Sale	12,000	23.84	286,044
2006-07-03	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	13,727	10.37	142,348
2006-07-03	Israel Robert J (Sr. VP, Medical Affairs)	Sale	5,000	23.84	119,185
2006-07-03	Israel Robert J (Sr. VP, Medical Affairs)	Option Ex	7,216	12.22	88,215
2006-06-21	Boyd Thomas A (Sr. VP, Product Dev.)	Sale	3,750	21.64	81,138
2006-06-21	Kremer Alton B (VP, Clinical Research)	Sale	875	21.60	18,900
2006-06-21	Maddon Paul J (Chief Executive Officer/CSO)	Sale	12,500	21.62	270,262
2006-06-21	Israel Robert J (Sr. VP, Medical Affairs)	Sale	900	21.60	19,440
2006-06-20	Olson William C (VP, Research & Development)	Sale	1,000	21.62	21,620
2006-06-20	Mckinney Robert A (Chief Financial Officer)	Sale	3,000	21.41	64,239
2006-06-01	Maddon Paul J (Chief Executive Officer/CSO)	Sale	10,000	21.83	218,340
2006-06-01	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	10,000	5.33	53,300
2006-06-01	Israel Robert J (Sr. VP, Medical Affairs)	Sale	5,000	21.84	109,220
2006-06-01	Israel Robert J (Sr. VP, Medical Affairs)	Option Ex	5,000	4.00	20,000
2006-05-15	Maddon Paul J (Chief Executive Officer/CSO)	Sale	10,000	20.91	209,090
2006-05-15	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	10,000	5.33	53,300
2006-05-05	Olson William C (VP, Research & Development)	Sale	3,893	24.00	93,432
2006-05-05	Olson William C (VP, Research & Development)	Option Ex	3,893	4.00	15,572
2006-05-04	Olson William C (VP, Research & Development)	Sale	10,107	24.00	242,568
2006-05-04	Olson William C (VP, Research & Development)	Option Ex	10,107	4.00	40,428
2006-05-01	Maddon Paul J (Chief Executive Officer/CSO)	Sale	10,000	23.52	235,200
2006-05-01	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	10,000	5.33	53,300
2006-05-01	Israel Robert J (Sr. VP, Medical Affairs)	Sale	5,000	23.51	117,550
2006-05-01	Israel Robert J (Sr. VP, Medical Affairs)	Option Ex	5,000	4.00	20,000
2006-04-17	Maddon Paul J (Chief Executive Officer/CSO)	Sale	10,000	25.00	250,020
2006-04-17	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	10,000	5.33	53,300
2006-04-03	Baker Mark Robert (General Counsel)	Option Ex	500	21.77	10,884
2006-04-03	Boyd Thomas A (Sr. VP, Product Dev.)	Option Ex	376	21.77	8,185
2006-04-03	Kremer Alton B (VP, Clinical Research)	Option Ex	611	21.77	13,300
2006-04-03	Olson William C (VP, Research & Development)	Option Ex	305	21.77	6,639
2006-04-03	Mckinney Robert A (Chief Financial Officer)	Option Ex	361	21.77	7,858
2006-04-03	Maddon Paul J (Chief Executive Officer/CSO)	Sale	10,000	25.86	258,640
2006-04-03	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	11,490	8.62	99,009
2006-04-03	Israel Robert J (Sr. VP, Medical Affairs)	Sale	5,000	26.16	130,780
2006-04-03	Israel Robert J (Sr. VP, Medical Affairs)	Option Ex	5,588	12.88	71,995
2006-03-20	Olson William C (VP, Research & Development)	Sale	2,000	27.46	54,920
2006-03-20	Olson William C (VP, Research & Development)	Option Ex	2,000	4.00	8,000
2006-03-15	Maddon Paul J (Chief Executive Officer/CSO)	Sale	10,000	27.00	270,040
2006-03-15	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	10,000	5.33	53,300
2006-03-01	Maddon Paul J (Chief Executive Officer/CSO)	Sale	10,000	29.02	290,210
2006-03-01	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	10,000	5.33	53,300
2006-03-01	Israel Robert J (Sr. VP, Medical Affairs)	Sale	10,000	29.02	290,210
2006-03-01	Israel Robert J (Sr. VP, Medical Affairs)	Option Ex	10,000	4.00	40,000
2006-02-27	Mckinney Robert A (Chief Financial Officer)	Sale	1,500	30.00	45,000
2006-02-27	Scheinberg David A (Director)	Sale	5,000	30.02	150,100
2006-02-27	Scheinberg David A (Director)	Option Ex	5,000	4.00	20,000
2006-02-21	Olson William C (VP, Research & Development)	Sale	2,000	28.01	56,020
2006-02-21	Olson William C (VP, Research & Development)	Option Ex	2,000	4.00	8,000
2006-02-15	Boyd Thomas A (Sr. VP, Product Dev.)	Sale	10,000	28.00	280,000
2006-02-15	Boyd Thomas A (Sr. VP, Product Dev.)	Option Ex	10,000	13.62	136,250
2006-02-15	Maddon Paul J (Chief Executive Officer/CSO)	Sale	10,000	27.17	271,680
2006-02-15	Maddon Paul J (Chief Executive Officer/CSO)	Option Ex	10,000	5.33	53,300
2006-02-15	Israel Robert J (Sr. VP, Medical Affairs)	Sale	1,858	28.00	52,024
2006-02-15	Israel Robert J (Sr. VP, Medical Affairs)	Option Ex	1,858	4.00	7,432
2006-02-06	Olson William C (VP, Research & Development)	Sale	2,000	24.45	48,906
2006-02-06	Olson William C (VP, Research & Development)	Option Ex	2,000	4.00	8,000
2006-02-01	Maddon Paul J (CSO)	Sale	10,000	27.73	277,270
2006-02-01	Maddon Paul J (CSO)	Option Ex	10,000	5.33	53,300
2006-02-01	Israel Robert J (SR. VP Medical Affai)	Sale	8,142	27.87	226,893
2006-02-01	Israel Robert J (SR. VP Medical Affai)	Option Ex	8,142	4.00	32,568
2006-01-30	Kremer Alton B (VP, Clinical Researc)	Sale	8,000	27.63	221,064
2006-01-30	Kremer Alton B (VP, Clinical Researc)	Option Ex	8,000	13.57	108,560
2006-01-03	Baker Mark Robert (General Counsel)	Option Ex	539	20.86	11,243
2006-01-03	Boyd Thomas A (SR. VP, Product Deve)	Option Ex	367	20.86	7,655
2006-01-03	Kremer Alton B (VP, Clinical Researc)	Option Ex	659	20.86	13,746
2006-01-03	Olson William C (VP, Research and Dev)	Option Ex	330	20.86	6,883
2006-01-03	Mckinney Robert A (Cheif Financial Officer)	Option Ex	390	20.86	8,135
2006-01-03	Maddon Paul J (CSO)	Option Ex	1,608	20.86	33,542
2006-01-03	Israel Robert J (SR. VP Medical Affai)	Option Ex	635	20.86	13,246
2005-09-13	Israel Robert J (SR. VP Medical Affai)	Sale	5,000	25.00	125,000
2005-06-21	Olson William C (VP, Research and Dev)	Sale	650	20.00	13,000
2005-06-21	Maddon Paul J (CSO)	Sale	6,250	20.02	125,156
2005-06-20	Boyd Thomas A (SR. VP, Product Deve)	Sale	750	19.85	14,887
2005-06-20	Mckinney Robert A (Cheif Financial Officer)	Sale	750	19.87	14,902
2005-06-20	Jacobson Paul F (Director)	Sale	3,000	19.85	59,550
2005-06-20	Israel Robert J (SR. VP Medical Affai)	Sale	750	19.87	14,902
2005-06-20	Goff Stephen P (Director)	Sale	3,000	19.85	59,550

Insider trading activities including stock purchases, stock sales, and option exercises of PGNX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Progenics Pharmaceuticals Inc (symbol PGNX, CIK number 835887) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month